Predictors of Durable Remission After Successful Surgery for Cushing Disease: Results From the Multicenter RAPID Registry.
Journal
Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914
Informations de publication
Date de publication:
21 Jun 2024
21 Jun 2024
Historique:
received:
31
01
2024
accepted:
14
04
2024
medline:
21
6
2024
pubmed:
21
6
2024
entrez:
21
6
2024
Statut:
aheadofprint
Résumé
Cushing disease (CD) affects mortality and quality of life along with limited long-term remission, underscoring the need to better identify recurrence risk. The identification of surgical or imaging predictors for CD remission after transsphenoidal surgery has yielded some inconsistent results and has been limited by single-center, single-surgeon, or meta-analyses studies. We sought to evaluate the multicenter Registry of Adenomas of the Pituitary and Related Disorders (RAPID) database of academic US pituitary centers to assess whether robust nonhormonal recurrence predictors could be elucidated. Patients with treated CD from 2011 to 2023 were included. The perioperative and long-term characteristics of CD patients with and without recurrence were assessed using univariable and multivariable analyses. Of 383 patients with CD from 26 surgeons achieving postoperative remission, 288 (75.2%) maintained remission at last follow-up while 95 (24.8%) showed recurrence (median time to recurrence 9.99 ± 1.34 years). Patients with recurrence required longer postoperative hospital stays (5 ± 3 vs 4 ± 2 days, P = .002), had larger average tumor volumes (1.76 ± 2.53 cm3 vs 0.49 ± 1.17 cm3, P = .0001), and more often previously failed prior treatment (31.1% vs 14.9%, P = .001) mostly being prior surgery. Multivariable hazard prediction models for tumor recurrence found younger age (odds ratio [OR] = 0.95, P = .002) and Knosp grade of 0 (OR = 0.09, reference Knosp grade 4, P = .03) to be protective against recurrence. Comparison of Knosp grade 0 to 2 vs 3 to 4 showed that lower grades had reduced risk of recurrence (OR = 0.27, P = .04). Other factors such as length of stay, surgeon experience, prior tumor treatment, and Knosp grades 1, 2, or 3 failed to reach levels of statistical significance in multivariable analysis. This multicenter study centers suggests that the strongest predictors of recurrence include tumor size/invasion and age. This insight can help with patient counseling and prognostication. Long-term follow-up is necessary for patients, and early treatment of small tumors may improve outcomes.
Sections du résumé
BACKGROUND AND OBJECTIVE
OBJECTIVE
Cushing disease (CD) affects mortality and quality of life along with limited long-term remission, underscoring the need to better identify recurrence risk. The identification of surgical or imaging predictors for CD remission after transsphenoidal surgery has yielded some inconsistent results and has been limited by single-center, single-surgeon, or meta-analyses studies. We sought to evaluate the multicenter Registry of Adenomas of the Pituitary and Related Disorders (RAPID) database of academic US pituitary centers to assess whether robust nonhormonal recurrence predictors could be elucidated.
METHODS
METHODS
Patients with treated CD from 2011 to 2023 were included. The perioperative and long-term characteristics of CD patients with and without recurrence were assessed using univariable and multivariable analyses.
RESULTS
RESULTS
Of 383 patients with CD from 26 surgeons achieving postoperative remission, 288 (75.2%) maintained remission at last follow-up while 95 (24.8%) showed recurrence (median time to recurrence 9.99 ± 1.34 years). Patients with recurrence required longer postoperative hospital stays (5 ± 3 vs 4 ± 2 days, P = .002), had larger average tumor volumes (1.76 ± 2.53 cm3 vs 0.49 ± 1.17 cm3, P = .0001), and more often previously failed prior treatment (31.1% vs 14.9%, P = .001) mostly being prior surgery. Multivariable hazard prediction models for tumor recurrence found younger age (odds ratio [OR] = 0.95, P = .002) and Knosp grade of 0 (OR = 0.09, reference Knosp grade 4, P = .03) to be protective against recurrence. Comparison of Knosp grade 0 to 2 vs 3 to 4 showed that lower grades had reduced risk of recurrence (OR = 0.27, P = .04). Other factors such as length of stay, surgeon experience, prior tumor treatment, and Knosp grades 1, 2, or 3 failed to reach levels of statistical significance in multivariable analysis.
CONCLUSION
CONCLUSIONS
This multicenter study centers suggests that the strongest predictors of recurrence include tumor size/invasion and age. This insight can help with patient counseling and prognostication. Long-term follow-up is necessary for patients, and early treatment of small tumors may improve outcomes.
Identifiants
pubmed: 38905223
doi: 10.1227/neu.0000000000003042
pii: 00006123-990000000-01223
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Barrow Neurological Foundation
Informations de copyright
Copyright © Congress of Neurological Surgeons 2024. All rights reserved.
Références
Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). J Neurosurg. 1964;21(4):318-347.
Lonser RR, Nieman L, Oldfield EH. Cushing's disease: pathobiology, diagnosis, and management. J Neurosurg. 2017;126(2):404-417.
Ayala A, Manzano AJ. Detection of recurrent Cushing's disease: proposal for standardized patient monitoring following transsphenoidal surgery. J Neurooncol. 2014;119(2):235-242.
Bunevicius A, Laws ER, Vance ML, Iuliano S, Sheehan J. Surgical and radiosurgical treatment strategies for Cushing's disease. J Neurooncol. 2019;145(3):403-413.
Tindall GT, Herring CJ, Clark RV, Adams DA, Watts NB. Cushing's disease: results of transsphenoidal microsurgery with emphasis on surgical failures. J Neurosurg. 1990;72(3):363-369.
Kim JH, Shin CS, Paek SH, Jung HW, Kim SW, Kim SY. Recurrence of Cushing's disease after primary transsphenoidal surgery in a university hospital in Korea. Endocr J. 2012;59(10):881-888.
Biller BM, Grossman AB, Stewart PM, et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2008;93(7):2454-2462.
Braun LT, Rubinstein G, Zopp S, et al. Recurrence after pituitary surgery in adult Cushing’s disease: a systematic review on diagnosis and treatment. Endocrine. 2020;70(2):218-231.
Chandler WF, Barkan AL, Hollon T, et al. Outcome of transsphenoidal surgery for cushing disease: a single-center experience over 32 years. Neurosurgery. 2016;78(2):216-223.
Catalino MP, Moore DT, Ironside N, et al. Postoperative serum cortisol and cushing disease recurrence in patients with corticotroph adenomas. J Clin Endocrinol Metab. 2023;108(12):3287-3294.
Lonser RR, Ksendzovsky A, Wind JJ, Vortmeyer AO, Oldfield EH. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease. J Neurosurg. 2012;116(2):272-279.
Stroud A, Dhaliwal P, Alvarado R, et al. Outcomes of pituitary surgery for Cushing's disease: a systematic review and meta-analysis. Pituitary. 2020;23(5):595-609.
Mohyeldin A, Katznelson LJ, Hoffman AR, et al. Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes. Sci Rep. 2022;12(1):9919.
Petersenn S, Beckers A, Ferone D, et al. Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. Eur J Endocrinol. 2015;172(6):R227-R239.
Liu Y, Liu X, Hong X, et al. Prediction of recurrence after transsphenoidal surgery for Cushing’s disease: the use of machine learning algorithms. Neuroendocrinology. 2019;108(3):201-210.
Acebes JJ, Martino J, Masuet C, Montanya E, Soler J. Early post-operative ACTH and cortisol as predictors of remission in Cushing’s disease. Acta Neurochir (Wien). 2007;149(5):471-479.
Zachariah MA, Cua S, Muhlestein WE, et al. Intraoperative predictor of remission in Cushing disease. Oper Neurosurg. 2023;24(4):460-467.
Flitsch J, Knappe UJ, Lüdecke DK. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing’s disease. Zentralbl Neurochir. 2003;64(1):6-11.
Abellán Galiana P, Fajardo Montañana C, Riesgo Suárez PA, Gómez Vela J, Meseguer Escrivá C, Rovira Lillo V. Predictors of long-term remission after transsphenoidal surgery in Cushing's disease. Endocrinol Nutr. 2013;60(8):475-482.
Barbot M, Albiger N, Koutroumpi S, et al. Predicting late recurrence in surgically treated patients with Cushing's disease. Clin Endocrinol. 2013;79(3):394-401.
Findlay MC, Drexler R, Azab M, et al. Crooke cell adenoma confers poorer endocrinological outcomes compared with corticotroph adenoma: results of a multicenter, international analysis. World Neurosurg. 2023;180:e376-e391.
Mehta GU, Ding D, Gupta A, et al. Repeat stereotactic radiosurgery for Cushing's disease: outcomes of an international, multicenter study. J Neurooncol. 2018;138(3):519-525.
Moreno-Moreno P, Ibanez-Costa A, Venegas-Moreno E, et al. Integrative clinical, radiological, and molecular analysis for predicting remission and recurrence of cushing disease. J Clin Endocrinol Metab. 2022;107(7):e2938-e2951.
Mastorakos P, Taylor DG, Chen CJ, Buell T, Donahue JH, Jane JA. Prediction of cavernous sinus invasion in patients with Cushing's disease by magnetic resonance imaging. J Neurosurg. 2018;130(5):1593-1598.
Araujo-Castro M, Acitores Cancela A, Vior C, Pascual-Corrales E, Rodríguez Berrocal V. Radiological Knosp, revised-Knosp, and Hardy-Wilson classifications for the prediction of surgical outcomes in the endoscopic endonasal surgery of pituitary adenomas: study of 228 cases. Front Oncol. 2021;11:807040.
Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure. Eur J Endocrinol. 2005;152(3):379-387.
Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33(4):610-618; discussion 617-618.
Araujo-Castro M, Pascual-Corrales E, Martínez-Vaello V, et al. Predictive model of surgical remission in acromegaly: age, presurgical GH levels and Knosp grade as the best predictors of surgical remission. J Endocrinol Invest. 2021;44(1):183-193.
Zoli M, Milanese L, Bonfatti R, et al. Cavernous sinus invasion by pituitary adenomas: role of endoscopic endonasal surgery. J Neurosurg Sci. 2016;60(4):485-494.
Braileanu M, Hu R, Hoch MJ, et al. Pre-operative MRI predictors of hormonal remission status post pituitary adenoma resection. Clin Imaging. 2019;55:29-34.
Erkan B, Barut O, Akbas A, et al. Results of endoscopic surgery in patients with pituitary adenomas: association of tumor classification grades with resection, remission, and complication rates. J Korean Neurosurg Soc. 2021;64(4):608-618.
Patil CG, Prevedello DM, Lad SP, et al. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab. 2008;93(2):358-362.
Barker FG 2nd, Klibanski A, Swearingen B. Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab. 2003;88(10):4709-4719.
Findling JW, Fleseriu M, Newell-Price J, et al. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study. Endocrine. 2016;54(2):516-523.
Mooney MA, Hardesty DA, Sheehy JP, et al. Interrater and intrarater reliability of the Knosp scale for pituitary adenoma grading. J Neurosurg. 2017;126(5):1714-1719.
Hinojosa-Amaya JM, Varlamov EV, McCartney S, Fleseriu M. Hypercortisolemia recurrence in Cushing's disease; a diagnostic challenge. Front Endocrinol (Lausanne). 2019;10:740.
Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540.
Fan Y, Li D, Liu Y, Feng M, Chen Q, Wang R. Toward better prediction of recurrence for Cushing’s disease: a factorization-machine based neural approach. Int J Mach Learn Cybern. 2021;12(3):625-633.
Laws ER, Catalino MP. Editorial. Machine learning and artificial intelligence applied to the diagnosis and management of Cushing disease. Neurosurg Focus. 2020;48(6):E6.
Zoli M, Staartjes VE, Guaraldi F, et al. Machine learning-based prediction of outcomes of the endoscopic endonasal approach in Cushing disease: is the future coming? Neurosurg Focus. 2020;48(6):E5.
Anwar SSM, Hilal K, Khan A, Ahmad A. Magnetic resonance imaging grading of pituitary macroadenoma - SIPAP classification revisited. Eur J Radiol Open. 2023;10:100486.